iSpecimen Inc (ISPC) Stock Analysis
Verdict: AVOID
Collapse in revenue and terminal margin decay suggest a failing business model with imminent liquidity risk.
Investment score: 12/100
Analysis as of
Is iSpecimen Inc stock worth reviewing? AI model thesis
iSpecimen is a micro-cap in a clear death spiral, characterized by an 87% revenue decline and massive earnings misses. Financial health is critical with negative gross margins and a current ratio below 1.0. The recent 25% price drop without news suggests market participants are pricing in insolvency or further massive dilution.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 10/100 (weight 10%)
- Risk-Adjusted Return: 5/100 (weight 15%)
iSpecimen Inc opportunities and risks
What speaks for ISPC
- Asset Value Play
What speaks against ISPC
- Terminal Liquidity Crunch
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ISPC | n/a | 0.5x | 0.4x | -108.3% | -2449.0% | -3484.3% |
| DTRK | 3.9x | 1.6x | 5.2x | 81.2% | 37.3% | 1.4% |
| HLYK | n/a | 5.9x | n/a | 98.0% | -289.3% | -28.4% |
| ACON | n/a | 17.4x | 1.7x | -51.0% | -10978.5% | -555.4% |
| IHAI | n/a | 0.0x | n/a | 0.0% | 0.0% | -14.9% |
| VSEE | n/a | 0.0x | n/a | 42.1% | -109.4% | -1162.5% |
| Peer median | n/a | 1.6x | n/a | 42.1% | -109.4% | -28.4% |
Frequently asked questions about iSpecimen Inc (ISPC)
Is ISPC stock a good investment?
The cached TradeMates AI model rates iSpecimen Inc as AVOID with an investment score of 12/100. iSpecimen is a micro-cap in a clear death spiral, characterized by an 87% revenue decline and massive earnings misses. Financial health is critical with negative gross margins and a current ratio below 1.0. The recent 25% price drop without news suggests market participants are pricing in insolvency or further massive dilution. This is algorithmic model output, not personal investment advice.
Is ISPC stock a buy?
The TradeMates model verdict for ISPC is AVOID with an investment score of 12/100. Treat this as a model signal to review, not a personal buy recommendation.